LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	GW843682X	0.12	uM	LJP6	72	hr	1657	3476	5383	0.6456	0.5456
BT-20	GW843682X	0.37	uM	LJP6	72	hr	1657	2170	5383	0.4027	0.1696
BT-20	GW843682X	3.33	uM	LJP6	72	hr	1657	1241	5383	0.2301	-0.1587
BT-20	GW843682X	10	uM	LJP6	72	hr	1657	1730	5383	0.3210	0.0238
BT-20	HG-5-113-01	1.11	uM	LJP5	72	hr	1657	3826	5588	0.6848	0.6114
BT-20	HG-5-113-01	3.33	uM	LJP5	72	hr	1657	2727	5588	0.4883	0.3272
BT-20	HG-5-88-01	0.04	uM	LJP6	72	hr	1657	4635	5383	0.8620	0.8330
BT-20	HG-5-88-01	0.12	uM	LJP6	72	hr	1657	5270	5383	0.9785	0.9741
BT-20	HG-5-88-01	3.33	uM	LJP6	72	hr	1657	4472	5383	0.8310	0.7936
BT-20	HG-5-88-01	10	uM	LJP6	72	hr	1657	3006	5383	0.5586	0.4192
BT-20	HG-6-64-01	0.12	uM	LJP6	72	hr	1657	5436	5383	1.0111	1.0135
BT-20	HG-6-64-01	0.37	uM	LJP6	72	hr	1657	4625	5383	0.8589	0.8282
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1657	5718	5588	1.0234	1.0266
BT-20	Seliciclib	0.12	uM	LJP5	72	hr	1657	5585	5588	0.9996	0.9994
BT-20	Seliciclib	1.11	uM	LJP5	72	hr	1657	4763	5588	0.8525	0.8258
BT-20	Seliciclib	3.33	uM	LJP5	72	hr	1657	4547	5588	0.8139	0.7783
BT-20	AT-7519	0.12	uM	LJP6	72	hr	1657	4313	5383	0.8018	0.7564
BT-20	AT-7519	0.37	uM	LJP6	72	hr	1657	1889	5383	0.3511	0.0799
BT-20	AT-7519	3.33	uM	LJP6	72	hr	1657	1217	5383	0.2261	-0.1671
BT-20	AT-7519	10	uM	LJP6	72	hr	1657	922	5383	0.1714	-0.2941
BT-20	AZD7762	1.11	uM	LJP6	72	hr	1657	2517	5383	0.4683	0.2793
BT-20	AZD7762	3.33	uM	LJP6	72	hr	1657	1552	5383	0.2891	-0.0378
BT-20	AZD8055	0.04	uM	LJP6	72	hr	1657	2584	5383	0.4793	0.2957
BT-20	Neratinib	0.37	uM	LJP5	72	hr	1657	4244	5588	0.7597	0.7095
BT-20	Neratinib	0.12	uM	LJP5	72	hr	1657	4407	5588	0.7888	0.7469

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)